Yalcin, A. D. Et Al. 2013. Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200. Asia Pacific Congress of Allergy, Asthma and Clinical Immunology , (Taipei, Taiwan), 20.

Yalcin, A. D., Genc, G. E., Celik, B., & GÜMÜŞLÜ, S., (2013). Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200 . Asia Pacific Congress of Allergy, Asthma and Clinical Immunology (pp.20). Taipei, Taiwan

Yalcin, A. Et Al. "Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200," Asia Pacific Congress of Allergy, Asthma and Clinical Immunology, Taipei, Taiwan, 2013

Yalcin, A. D. Et Al. "Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200." Asia Pacific Congress of Allergy, Asthma and Clinical Immunology , Taipei, Taiwan, pp.20, 2013

Yalcin, A. D. Et Al. (2013) . "Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200." Asia Pacific Congress of Allergy, Asthma and Clinical Immunology , Taipei, Taiwan, p.20.

@conferencepaper{conferencepaper, author={A. D. Yalcin Et Al. }, title={Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and effects on soluble CD200}, congress name={Asia Pacific Congress of Allergy, Asthma and Clinical Immunology}, city={Taipei}, country={Taiwan}, year={2013}, pages={20} }